Bluejay Diagnostics Stock

Bluejay Diagnostics Debt/EBITDA

Total Debt to EBITDA Ratio of Bluejay Diagnostics (BJDX) as of Aug 23, 2026.

Debt/EBITDA

-0.00

YoY

-27.67%

Last updated:

Total Debt to EBITDA Ratio of Bluejay Diagnostics is 2026 -0.00 . Total Debt to EBITDA Ratio of Bluejay Diagnostics was 2025 -0.00 . It decreases by -27.67% higher compared to the previous year.

The Bluejay Diagnostics Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
-0.66 USD
Jan 1, 2020
-0.88 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
-0.00 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2024
-0.00 USD
Jan 1, 2025
-0.00 USD
The Bluejay Diagnostics Debt/EBITDA history
YEARDebt/EBITDAYoY
-0.00-27.67%
-0.00+12.70%
-0.00-22.72%
-0.00—
0.00-100.00%
-0.88+34.56%
-0.66—
Access this data via the Eulerpool API
Get Free API Key

Bluejay Diagnostics Stock analysis

What does Bluejay Diagnostics do? Bluejay Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bluejay Diagnostics stock

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Bluejay Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Bluejay Diagnostics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Bluejay Diagnostics

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Bluejay Diagnostics